Suppr超能文献

人类中枢神经系统中的少突胶质细胞异质性。

Oligodendroglia heterogeneity in the human central nervous system.

机构信息

Centre for Regenerative Medicine, Institute for Regeneration and Repair, Edinburgh BioQuarter, University of Edinburgh, Edinburgh, UK.

出版信息

Acta Neuropathol. 2022 Feb;143(2):143-157. doi: 10.1007/s00401-021-02390-4. Epub 2021 Dec 3.

Abstract

It is the centenary of the discovery of oligodendrocytes and we are increasingly aware of their importance in the functioning of the brain in development, adult learning, normal ageing and in disease across the life course, even in those diseases classically thought of as neuronal. This has sparked more interest in oligodendroglia for potential therapeutics for many neurodegenerative/neurodevelopmental diseases due to their more tractable nature as a renewable cell in the central nervous system. However, oligodendroglia are not all the same. Even from the first description, differences in morphology were described between the cells. With advancing techniques to describe these differences in human tissue, the complexity of oligodendroglia is being discovered, indicating apparent functional differences which may be of critical importance in determining vulnerability and response to disease, and targeting of potential therapeutics. It is timely to review the progress we have made in discovering and understanding oligodendroglial heterogeneity in health and neuropathology.

摘要

这是发现少突胶质细胞的一百周年,我们越来越意识到它们在大脑发育、成人学习、正常衰老以及整个生命周期中的疾病中的重要性,甚至在那些经典上被认为是神经元疾病中也是如此。这激发了人们对少突胶质细胞在许多神经退行性/神经发育性疾病中的潜在治疗作用的更多兴趣,因为它们在中枢神经系统中是一种可再生的细胞,因此更具可操作性。然而,少突胶质细胞并非完全相同。即使在最初的描述中,也描述了细胞之间形态的差异。随着描述人类组织中这些差异的技术的进步,少突胶质细胞的复杂性正在被发现,表明明显的功能差异,这可能对确定疾病的易感性和反应以及潜在治疗方法的靶向性至关重要。现在是时候回顾一下我们在发现和理解健康和神经病理学中少突胶质细胞异质性方面所取得的进展了。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b117/8742806/c1fba5349639/401_2021_2390_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验